We are live on
!
Find out more
AC
Alexandria Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
-0.02%
1 Year Est. Return
+29.48%
3 Year Est. Return
+66.81%
5 Year Est. Return
+127.84%
10 Year Est. Return
–
AUM
$1.08B
AUM Growth
+$1.6M
(+0.15%)
Cap. Flow
-$10.6M
Cap. Flow
% of AUM
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
25.11%
Holding
269
New
3
Increased
97
Reduced
102
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$1.59M |
| 2 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$1.36M |
| 3 |
Johnson & Johnson
JNJ
|
+$1.1M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$890K |
| 5 |
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
|
+$848K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$651K |
| 2 |
iShares MSCI India Small-Cap ETF
SMIN
|
+$555K |
| 3 |
Apple
AAPL
|
+$506K |
| 4 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$482K |
| 5 |
Nektar Therapeutics
NKTR
|
+$430K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.34% |
| 2 | Healthcare | 9.51% |
| 3 | Communication Services | 8.96% |
| 4 | Financials | 7.57% |
| 5 | Consumer Discretionary | 4.92% |
No holdings matched the selected filter criteria.
Similar funds
WAM
DIC
CCP
KFM
OAM
SIM
LBD
FMT
Alexandria Capital's Q3 2021 Portfolio in Review
As of Q3 2021, Alexandria Capital held 269 positions worth $1.08B, up 0.15% from $1.08B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Alexandria Capital's Q3 2021 filing shows 3 new, 97 increased, 102 reduced and 15 closed positions. Its largest new stake was Illinois Tool Works: 1,032 shares worth $213K. The largest sale was Alnylam Pharmaceuticals, an estimated $651K.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.
- Alexandria Capital's largest Q3 2021 buy was Illinois Tool Works: 1,032 shares worth $213K.
- Alexandria Capital added most to iShares MSCI Emerging Markets ex China ETF in Q3 2021, an estimated $1.59M increase.
- Alexandria Capital's biggest Q3 2021 reduction was Alnylam Pharmaceuticals, cutting an estimated $651K.
- Alexandria Capital fully exited Nektar Therapeutics in Q3 2021, selling an estimated $430K.
- Alexandria Capital's ten largest holdings make up 25% of its $1.08B portfolio in Q3 2021.
- Alexandria Capital opened 3 new positions and closed 15 in Q3 2021.
- Alexandria Capital's portfolio value rose 0.15% quarter-over-quarter to $1.08B.
Based on Alexandria Capital's 13F filing for Q3 2021, filed 2 Dec 2021.